World-first: therapy to make cells young again given to a person
SMRTR summary
A Boston company has given a glaucoma patient the first gene therapy aimed at rejuvenating aging cells, activating three genes to regenerate damaged optic nerve neurons, with plans to treat up to 12 patients.
SMRTR provides this summary for quick context. The original article belongs to Scientific American.
Read the original article